Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GTHP Guided Therapeutics	$0.28 +8.4%	$0.24	$0.06 ▼ $0.32	$22.08M	0.18	10,191 shs	4,739 shs
INO Inovio Pharmaceuticals	$1.86 +14.8%	$1.67	$1.30 ▼ $8.01	$68.21M	1.38	1.85 million shs	11.66 million shs
RBOT Vicarious Surgical	$6.80 -8.8%	$8.73	$5.00 ▼ $19.00	$40.32M	1.41	36,368 shs	37,990 shs
SPAI Safe Pro Group	$3.84 +0.3%	$3.24	$1.47 ▼ $6.50	$58.26M	N/A	262,022 shs	36,388 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GTHP Guided Therapeutics	0.00%	+94.90%	+10.00%	+120.00%	+133.05%
INO Inovio Pharmaceuticals	0.00%	+31.91%	+33.81%	-10.14%	-76.25%
RBOT Vicarious Surgical	0.00%	-26.53%	-34.01%	-10.64%	+16.44%
SPAI Safe Pro Group	0.00%	-7.25%	-4.00%	+28.86%	+383,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GTHP Guided Therapeutics	0.5161 of 5 stars	0.0	3.0	0.0	2.0	1.7	0.0
INO Inovio Pharmaceuticals	4.0423 of 5 stars	3.3	4.0	4.4	2.4	0.0	0.6
RBOT Vicarious Surgical	0.8063 of 5 stars	1.0	2.0	0.0	2.4	2.5	0.6
SPAI Safe Pro Group	0.717 of 5 stars	2.0	0.0	0.0	1.9	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GTHP Guided Therapeutics	0.00	N/A	N/A	N/A
INO Inovio Pharmaceuticals	2.60	Moderate Buy	$8.80	373.12% Upside
RBOT Vicarious Surgical	2.00	Hold	$7.00	2.94% Upside
SPAI Safe Pro Group	4.00	Strong Buy	$8.00	108.33% Upside

Current Analyst Ratings Breakdown

Latest GTHP, SPAI, RBOT, and INO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/14/2025	INO Inovio Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$3.00
8/13/2025	RBOT Vicarious Surgical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$8.50 ➝ $7.00
7/17/2025	SPAI Safe Pro Group	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$8.00
7/9/2025	INO Inovio Pharmaceuticals	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$5.00

(Data available from 8/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GTHP Guided Therapeutics	$10K	2,207.70	N/A	N/A	($0.12) per share	-2.29
INO Inovio Pharmaceuticals	$220K	310.03	N/A	N/A	$1.90 per share	0.98
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	$7.89 per share	N/A
SPAI Safe Pro Group	$2.05M	28.47	N/A	N/A	$0.28 per share	13.71

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GTHP Guided Therapeutics	-$2.42M	-$0.05	N/A	∞	N/A	N/A	N/A	-208.01%	N/A
INO Inovio Pharmaceuticals	-$107.25M	-$2.61	N/A	N/A	N/A	N/A	-163.32%	-96.41%	N/A
RBOT Vicarious Surgical	-$63.22M	-$10.09	N/A	N/A	N/A	N/A	-148.14%	-98.07%	N/A
SPAI Safe Pro Group	-$7.43M	-$0.80	N/A	∞	N/A	-731.46%	-305.52%	-232.73%	9/25/2025 (Estimated)

Latest GTHP, SPAI, RBOT, and INO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	GTHP Guided Therapeutics	N/A	-$0.01	N/A	-$0.01	N/A	$0.12 million
8/14/2025	Q2 2025	SPAI Safe Pro Group	N/A	-$0.13	N/A	-$0.13	N/A	$0.09 million
8/12/2025	Q2 2025	INO Inovio Pharmaceuticals	-$0.63	-$0.61	+$0.02	-$0.61	$0.01 million	N/A
8/12/2025	Q2 2025	RBOT Vicarious Surgical	-$2.61	-$2.23	+$0.38	-$2.23	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GTHP Guided Therapeutics	N/A	N/A	N/A	N/A	N/A
INO Inovio Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	N/A
SPAI Safe Pro Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GTHP Guided Therapeutics	N/A	0.14	0.03
INO Inovio Pharmaceuticals	N/A	1.66	2.63
RBOT Vicarious Surgical	N/A	5.11	5.05
SPAI Safe Pro Group	0.06	1.70	1.34

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GTHP Guided Therapeutics	9.69%
INO Inovio Pharmaceuticals	26.79%
RBOT Vicarious Surgical	47.27%
SPAI Safe Pro Group	N/A

Insider Ownership

Company	Insider Ownership
GTHP Guided Therapeutics	66.83%
INO Inovio Pharmaceuticals	2.30%
RBOT Vicarious Surgical	11.99%
SPAI Safe Pro Group	54.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GTHP Guided Therapeutics	5	80.28 million	26.63 million	Not Optionable
INO Inovio Pharmaceuticals	320	36.67 million	35.83 million	Optionable
RBOT Vicarious Surgical	210	5.93 million	5.22 million	No Data
SPAI Safe Pro Group	11	15.17 million	6.86 million	N/A

GTHP, SPAI, RBOT, and INO Headlines

Recent News About These Companies

Safe Pro Group (NASDAQ:SPAI) Posts Quarterly Earnings Results

August 16 at 9:52 PM | marketbeat.com

Safe Pro Group Second Quarter 2025 Earnings: US$0.13 loss per share (vs US$0.14 loss in 2Q 2024)

August 16 at 11:23 AM | finance.yahoo.com

Safe Pro Group (NASDAQ: SPAI) Expands Global Patent Protection for AI-Based Explosives Detection

August 8, 2025 | theglobeandmail.com

Financial Analysis: Safe Pro Group (SPAI) versus Its Rivals

August 8, 2025 | americanbankingnews.com

Safe Pro Group Advances its AI Patent Protection Internationally, Receiving Publication Notifications in Australia, Israel, and European Region

August 7, 2025 | financialpost.comF

Safe Pro Group Advances its AI Patent Protection Internationally, Receiving Publication Notifications in Australia, Israel, and European Region

August 7, 2025 | globenewswire.com

Safe Pro to Capitalize on Landmark Proposed FAA Rules Normalizing Drone Operations Utilizing Beyond Visual Line of Sight with Expanded AI-Powered Drone Services

August 6, 2025 | globenewswire.com

Safe Pro Group Inc. Selected for Dual Roles in U.S. Army's 2026 Concept Focused Warfighter Experiment

August 5, 2025 | quiverquant.comQ

U.S. Army Selects Safe Pro's Artificial Intelligence Technology for Dual Participation in the Concept Focused Warfighter Experiment 2026, Including Live Breach Maneuver

August 5, 2025 | globenewswire.com

SafePro Dips on Army Selection for Product

July 30, 2025 | baystreet.ca

Safe Pro selected by U.S. Army to participate in AFC CFWE-M 2026 event

July 30, 2025 | msn.com

Safe Pro Group’s Drone-Powered Artificial Intelligence Technology Selected by the U.S. Army Futures Command for 2026 Exercise

July 30, 2025 | finance.yahoo.com

Safe Pro Group's Drone-Powered Artificial Intelligence Technology Selected by the U.S. Army Futures Command for 2026 Exercise

July 30, 2025 | globenewswire.com

SPARC AI Closes Non-Brokered Private Placement Offering

July 28, 2025 | thenewswire.comT

Safe Pro Group Successfully Integrates Artificial Intelligence-Powered Landmine Detection for Drones Selected Under U.S. Army Program of Record

July 21, 2025 | businesswire.com

Brokers Issue Forecasts for Safe Pro Group FY2025 Earnings

July 21, 2025 | marketbeat.com

Litchfield Hills Initiates Coverage of Safe Pro Group (SPAI) with Buy Recommendation

July 18, 2025 | msn.com

Safe Pro Selected by U.S. Government Contractor to Provide Ballistic Protection Gear in Indo-Asia Pacific Region & Demonstrate AI-Powered Drone Technology for Landmine Detection

July 18, 2025 | accessnewswire.comA

Safe Pro Group (NASDAQ: SPAI) Named Finalist in UN WFP Innovation Program for AI-Powered Landmine Detection

July 11, 2025 | theglobeandmail.com

Safe Pro Group Inc.: Safe Pro's Artificial Intelligence Selected as Finalist by UN World Food Programme for Humanitarian Innovation Accelerator from Among 579 Applicants ...

July 11, 2025 | finanznachrichten.de

Safe Pro's Artificial Intelligence Selected as Finalist by UN World Food Programme for Humanitarian Innovation Accelerator from Among 579 Applicants Spanning 103 Countries

July 10, 2025 | accessnewswire.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

GTHP, SPAI, RBOT, and INO Company Descriptions

Guided Therapeutics OTCMKTS:GTHP

$0.28 +0.02 (+8.35%)

As of 08/15/2025 02:51 PM Eastern

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Inovio Pharmaceuticals NASDAQ:INO

$1.86 +0.24 (+14.81%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$1.86 +0.00 (+0.27%)

As of 06:35 AM Eastern

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Vicarious Surgical NYSE:RBOT

$6.80 -0.66 (-8.85%)

Closing price 08/15/2025 03:57 PM Eastern

Extended Trading

$6.99 +0.19 (+2.79%)

As of 04:34 AM Eastern

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Safe Pro Group NASDAQ:SPAI

$3.84 +0.01 (+0.26%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$3.78 -0.05 (-1.43%)

As of 05:17 AM Eastern

Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time